← SynDRA
gonadorelin
SynDRA canonical compound SYN0041797 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | GNRH1 | GNRHR |
|---|
| Mechanism of action | gonadotropin releasing factor hormone receptor agonist |
|---|
| Indication | cystic ovaries | reproductive synchrony |
|---|
| Disease area | obstetrics/gynecology |
|---|
All known targets
Mechanisms of action (all sources)
- GNRHR AGONIST
- Gonadotropin-releasing hormone receptor agonist
- gonadotropin releasing factor hormone receptor agonist
ATC classes
- H01C · HYPOTHALAMIC HORMONES
- V04C · OTHER DIAGNOSTIC AGENTS
Cross-references
Synonyms
- Luteinizing hormone-releasing factor (swine)
- hypocrine
- fertagyl
- gonadorelin hydrochloride
- gonadorelin acetate
- gonadorelin HCl
- gonadorelin diacetate tetrahydrate
- Gonadoreline
- Gonadorelina
- Gonadorelin decapeptide
- Gonadotropin-releasing hormone
- Fertiral lh-rh
- Relefact lh-rh
- Dirigestran
- Factrel
- Fertagyl
- Gonadorelinum
- Hypocrine
- Kryptocur
- LFRH
- LHFSHRH
- Luforan
- Luliberin
- Lutal
- Lutamin
- Lutrefact
- Relefact
- Relisorm
- Dirigestran Spofa
- Gonadoliberin I
- LHFSH Releasing Hormone
- LUTEINIZING HORMONE
- Lutrepulse KIT
- MammalianGnRH
- Relisorm l
- Synthetic LRF
- Synthetic gonadoliberin
- HOE 471
Reported adverse events
- Headache
- Abdominal pain
- Atelectasis
- Injection site inflammation
- Injection site pain
- Injection
Look up gonadorelin in the interactive SynDRA portal →